期刊文献+

ⅠB~ⅡB期宫颈癌盆腔淋巴结转移相关因素分析 被引量:6

Analysis of factors affecting lymph node metastasis in FIGOⅠB toⅡB uterine cervical cancer
下载PDF
导出
摘要 目的:分析IB^IIB期宫颈癌盆腔淋巴结转移情况及相关高危因素,为早期宫颈癌的手术方式提供参考。方法:对158例进行广泛性全子宫切除术联合盆腔淋巴结清扫的IB^IIB期宫颈癌患者的临床病理资料进行回顾性分析,对影响淋巴结转移的因素采用logistic回归分析。结果:158例IB^IIB期宫颈癌有36例淋巴结转移阳性,转移率为22.8%,其中闭孔淋巴结转移22例(占13.9%),髂内淋巴结转移15例(占9.5%),髂外淋巴结转移10例(占6.3%),髂总淋巴结转移7例(占4.4%),腹股沟深淋巴结转移4例(占2.5%),宫旁淋巴结转移1例(占0.6%),腹主动脉旁淋巴结转移1例(占0.6%)。21例孤立淋巴结阳性,15例多组淋巴结阳性。单因素分析结果显示肿瘤直径大小超过4 cm,术前鳞状细胞癌抗原(SCC-Ag)及宫旁浸润与盆腔淋巴结转移相关(P<0.05)。logistic回归分析结果显示肿瘤直径超过4 cm及宫旁浸润是盆腔淋巴结转移的独立危险因素(P<0.05)。结论:IB^IIB期宫颈癌盆腔淋巴结转以闭孔淋巴结最易受累,肿瘤直径超过4 cm及宫旁浸润是盆腔淋巴结转移的高危因素。 Objective:To analysis the factors affecting lymph node metastasis in stage IB1 to IIB uterine cervical cancer. Methods:A total of 158 patients with stage IB to IIB cervical carcinomas treated with radical hysterectomy and systematic pelvic lymphadenectomy were retrospectively analyzed. The logistic multivariate analysis was used to select independent high-risk factors. Results:Thirty-six (22.8%) patients had pelvic lymph node metastasis. Of 36 lymph node metastases, 22 were in the obturator, 15 in the internal iliac, 10 in the external iliac, 7 in the common iliac, 4 in the deep inguinal, 1 in the parametrial iliac and 1 in the para aortic. Univari-ate analysis revealed that tumor size, preoperative SCC-Ag level and parametrial invasion were related to pelvic lymph node metastasis. Multivariate analysis revealed that tumor size greater than 4 cm and parametrial invasion were independently associated with nodal metastasis. Conclusion:The obturator lymph nodes are most frequent-ly involved in stage IB^IIB uterine cervical cancer. Tumor size greater than 4 cm and parametrial invasion are high-risk factors of pelvic lymph node metastasis.
出处 《温州医学院学报》 CAS 2015年第4期248-251,共4页 Journal of Wenzhou Medical College
基金 浙江省自然科学基金资助项目(Y2090699)
关键词 宫颈肿瘤 盆腔淋巴结转移 肿瘤大小 宫旁浸润 回归分析 uterine cervical neoplasms pelvic lymph node metastasis tumor size parametrial invasion:regression analysis
  • 相关文献

参考文献26

  • 1Cormier B, Diaz JP, Shih K, et al. Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer[J]. Gynecol Oncol, 2011,122(2): 275-280.
  • 2Roy M, Bouchard-Fortier G, Popa I, et al. Value of senti- nel node mapping in cancer of the cervix[J]. Gynecol Oncol, 2011, 122(2): 269-274.
  • 3Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among popula- tion controls[J]. Int J Gynecol Cancer, 2006, 16(3): 1130- 1139.
  • 4Tada H, Teramukai S, Fukushima M, et al. Risk factors for lower limb lymphedema after lymph node dissection in pa- tients with ovarian and uterine carcinoma[J]. BMC Cancer, 2009, 9(47): 1-6.
  • 5Frumovitz M, Sun CC, Schmeler KM, et al. Parametrial in- volvement in radical hysterectomy specimens for women with early-stage cervical cancer[J]. Obstet Gynecol, 2009, 114(1): 93-102.
  • 6Kodama J, Kusumoto T, Nakamura K, et al. Factors associ- ated with parametrial involvement in stage IB 1 cervical can- cer and identification of patients suitable for less radical sur- gery[J]. Gynecol Oncol, 2011, 122(3): 491-494.
  • 7Murakarni I, Fujii T, Kameyama K, et al. Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix[J]. J Gyneeol Oncol, 2012, 23(3): 153-158.
  • 8Meirovitz M, Sade S, Dreiher J, et al. Is radical hysterectomy necessary in early cervical cancer?[J]. Gynecol Obstet Invest, 2013, 76(3): 158-162.
  • 9Hosaka M, Watari H, Mitamura T, et al. Survival and prog- nosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy [J]. Int J Clin Oncol, 2011, 16(1): 33-38.
  • 10Kasamatsu T, Onda T, Sawada M, et al. Radical hysterectomy for FIGO stage l-liB adenocarcinoma of the uterine cervix [J]. Br J Cancer, 2009, 100(9): 1400-1405.

二级参考文献27

  • 1康旻,杜玉开.宫颈癌淋巴转移的机制及淋巴管内皮标记[J].中国组织化学与细胞化学杂志,2009,18(1):108-112. 被引量:1
  • 2冯淑瑜,张彦娜,刘建刚.宫颈癌淋巴结转移的高危因素及预后分析[J].癌症,2005,24(10):1261-1266. 被引量:71
  • 3Selzman AA, Sprinak JE Iatrogenic ureteral injuries: a 20- year experience in treating 165 injuries[J]. J Urol, 1996,155(10):878-881.
  • 4Casasola Chamorro J, Gutierrez Garcia S, Suarez Mayor M. Urinoma secondary to ureteral iatrogenic lesion[J]. Arch Esp Urol,2008,61(5):624-626.
  • 5Labasky RF,Leach GE.Prevention and management of urovaginal fistulas[J].Clin Obstet Gynecol,1990,33(2):382- 391.
  • 6De Cicco C, Ret Davalos ML, Van Cleynenbreugel B, et al.Iatrogenic ureteral lesions and repair:a review for gynecologists[J]. J Minim Invasive Gynecol,2007,14(4):428-435.
  • 7Sancher Merino JM,Guillian Maquieira C,Paria Muntaner L, et al.Transvesical repair of non-complicated vesicovagina fistula[J].Acta Urol Esp,2000,24(2): 185-189.
  • 8Chou MT, Wang C J, Lien RC.Prophylactic ureteral catheterization in gynecologic surgery:a 12-year randomized trial in a community hospital[J]. Int Urogynecol J Pelvic Floor Dysfunct,2009,20(6):689-693.
  • 9吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2004.589-591.
  • 10Chung HH, Kang SB, Cho JY,et al. Can preoperative MRI accu- rately evaluate nodal and parametrial invasion in early stage cer- vical cancer? [J]. Jpo J Clin Oncol,2007,37:370.

共引文献21

同被引文献48

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部